Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

Viatris

Status: Completed

Conditions: Pain Associated With Fibromyalgia

Treatments: Drug: Pregabalin

Study type: Observational

Funder types: Industry

Identifiers

NCT01773993

A0081282

Details and patient eligibility

About

To collect the efficacy and safety information of Pregabalin on Fibromyalgia patients related to their appropriate use in daily practice.

Full description

All the patients whom an investigator prescribes the first pregabalin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 534 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of Fibromyalgia
• Pregabalin naive patient

Exclusion criteria

• Clinical diagnosis of neuropathic pain

Trial design

534 participants in 1 patient group

Pregabalin

Description:

Subjects who are treated with pregabalin

Treatment:

Drug: Pregabalin